KPJ Healthcare’s (KPJ) 2QFY24 core net profit increased by 71.2% YoY to RM77.6m from RM45.3m in 2QFY23, mainly driven by higher BOR and influx of patients visits. The results were in line with our estimates at 50% but fell short of street’s estimates at 44% of full-year forecast respectively. KPJ’s revenue was up 18.5% YoY, mainly boosted by a higher BOR of 66% in 2QFY24. We maintain our FY24F-26F earnings forecasts and reiterate our Outperform rating with an unchanged SOTP-based TP of RM2.21 based on FY25 12x EV/EBITDA (near Malaysia hospital average). KPJ declared an interim dividend of 1.0 sen per share (bringing the total DPS to 3.0sen for FY24).
Source: PublicInvest Research - 29 Aug 2024
Chart | Stock Name | Last | Change | Volume |
---|
2024-12-19
KPJ2024-12-18
KPJ2024-12-17
KPJ2024-12-17
KPJ2024-12-17
KPJ2024-12-16
KPJ2024-12-16
KPJ2024-12-16
KPJ2024-12-16
KPJ2024-12-13
KPJ2024-12-13
KPJ2024-12-13
KPJ2024-12-13
KPJ2024-12-13
KPJ2024-12-12
KPJ2024-12-12
KPJ2024-12-12
KPJ2024-12-12
KPJ2024-12-12
KPJ2024-12-11
KPJ2024-12-11
KPJ2024-12-11
KPJ2024-12-11
KPJ2024-12-11
KPJ2024-12-11
KPJ2024-12-11
KPJ2024-12-10
KPJ2024-12-10
KPJ2024-12-10
KPJCreated by PublicInvest | Dec 19, 2024